nanoNIPT: Short‐fragment nanopore sequencing of cell‐free DNA for non‐invasive prenatal testing of fetal aneuploidies and sex chromosome aberrations
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Maria Winther Jørgensen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Nanopore Sequencing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Region Syddanmark Research Fund.
Abstract (Originalsprache)
Key points What's already known about this topic? Non‐invasive prenatal testing (NIPT) is a sensitive and risk‐free prenatal screening test for common aneuploidies. Until now, NIPT has required access to expensive next generation sequencing (NGS) sequencers, making it only accessible to large laboratories. What does this study add? This proof‐of‐concept study demonstrates that Oxford Nanopore platform, originally developed for long‐reads, can be used to sequence and analyze short cell‐free DNA (cfDNA) fragments with high efficiency and accuracy. We developed nanoNIPT for non‐invasive detection of fetal aneuploidies and sex chromosome aberrations, which enables NIPT testing without large upfront investments making it accessible in all the clinical labs around the world.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
- Human Genetics Unit, Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Maria Winther Jørgensen, Ieva Miceikaitė, Martin J Larsen
Förderung
- Region Syddanmark Research Fund
Zitieren
APA
Jørgensen, M. W., Miceikaitė, I., & Larsen, M. J. (2023). nanoNIPT: Short‐fragment nanopore sequencing of cell‐free DNA for non‐invasive prenatal testing of fetal aneuploidies and sex chromosome aberrations. Prenatal Diagnosis. https://doi.org/10.1002/pd.6331
Vancouver
Jørgensen MW, Miceikaitė I, Larsen MJ. nanoNIPT: Short‐fragment nanopore sequencing of cell‐free DNA for non‐invasive prenatal testing of fetal aneuploidies and sex chromosome aberrations. Prenatal Diagnosis. 2023. doi:10.1002/pd.6331
BibTeX
@article{Jrgensen2023,
author = {Jørgensen, Maria Winther and Miceikaitė, Ieva and Larsen, Martin J},
title = {nanoNIPT: Short‐fragment nanopore sequencing of cell‐free DNA for non‐invasive prenatal testing of fetal aneuploidies and sex chromosome aberrations},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6331}
}
EUVIMED